GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Change In Receivables

Hamlet BioPharma AB publ (XSAT:HAMLET B) Change In Receivables : kr0.24 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Change In Receivables?

Hamlet BioPharma AB publ's change in receivables for the quarter that ended in Mar. 2025 was kr-0.10 Mil. It means Hamlet BioPharma AB publ's Accounts Receivable increased by kr0.10 Mil from Dec. 2024 to Mar. 2025 .

Hamlet BioPharma AB publ's change in receivables for the fiscal year that ended in Jun. 2024 was kr-3.58 Mil. It means Hamlet BioPharma AB publ's Accounts Receivable increased by kr3.58 Mil from Jun. 2023 to Jun. 2024 .

Hamlet BioPharma AB publ's Accounts Receivable for the quarter that ended in Mar. 2025 was kr0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hamlet BioPharma AB publ's liquidation value for the three months ended in Mar. 2025 was kr15.27 Mil.


Hamlet BioPharma AB publ Change In Receivables Historical Data

The historical data trend for Hamlet BioPharma AB publ's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Change In Receivables Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.68 -3.99 3.14 1.50 -3.58

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.74 1.20 0.06 -0.93 -0.10

Hamlet BioPharma AB publ Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hamlet BioPharma AB publ's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

2. In Ben Graham's calculation of liquidation value, Hamlet BioPharma AB publ's accounts receivable are only considered to be worth 75% of book value:

Hamlet BioPharma AB publ's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=20.027-4.762+0.75 * 0+0.5 * 0
=15.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines